crypto paying, Overview

Deputy Prime Minister of Ukraine: We are ready to discuss the deployment of foreign troops in our own territory. On December 12, local time, the reporter of the General Desk learned that Ukrainian Deputy Prime Minister Stefani Hina said that Ukraine is ready to discuss the deployment of foreign troops in its own territory. It is reported that French President Macron and Polish Prime Minister Tusk plan to exchange views on the deployment of about 40,000 peacekeepers in Uzbekistan on the 12th. (CCTV News)Treasury futures turned green for 30 years, and treasury futures turned down. The 30-year main contracts turned green and fell by 0.03% to 116.94. The 10-year main contract was reported at 108.17, and the increase narrowed to 0.02%.People's Insurance Company of China: In the first November, the original insurance premium income of the three subsidiaries totaled 646.933 billion yuan. From January 1, 2024 to November 30, 2024, the original insurance premium income obtained through the subsidiaries of China People's Property Insurance Co., Ltd., China People's Life Insurance Co., Ltd. and China People's Health Insurance Co., Ltd. was 496.845 billion yuan, 102.591 billion yuan and 47.497 billion yuan respectively.

Xiamen Tungsten Xinneng: Signed a strategic cooperation framework agreement for solid-state batteries with Xinwangda Power. Xiamen Tungsten Xinneng announced that the company and Xinwangda Power signed the Strategic Cooperation Framework Agreement for Solid-state Batteries on December 11, 2024. The two sides will give full play to their respective advantages in market and technology, promote the industrialization of a series of new energy battery materials for solid-state batteries, establish a deep-seated strategic cooperative relationship, jointly develop a series of new energy battery materials for solid-state batteries, and further expand business cooperation at an appropriate time.Schlegel, Governor of the Swiss National Bank: Since the last interest rate decision, the inflation rate has been lower than expected. The development of the Swiss franc is still an important factor.Alleged of tax evasion, Adidas' German headquarters was raided for two days in a row. On December 11th, local time, criminal prosecutors and customs investigators raided Adidas' German headquarters for the second day in a row, which was an escalation of years of investigation on the sports brand's alleged tax evasion. The amount of tax evasion may exceed 1.1 billion euros. The European Prosecutor's Office (EPPO), headquartered in Luxembourg, said on the 11th that it was conducting a "criminal investigation" against a German sportswear trading enterprise group on the grounds that it was "suspected of tax evasion related to customs duties and import and sales taxes". Adidas said that this long-term investigation is unlikely to have "any significant financial impact".

The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.In 2023, the trade volume between the mainland and Macao increased by 4.3 times compared with that before the reunification. At the regular press conference held by the Ministry of Commerce today (12th), spokesman He Yadong introduced that by signing CEPA and its series of agreements, the mainland has fully liberalized its trade in goods and basically liberalized its trade in services. According to statistics, in 2023, the trade volume between the mainland and Macao was 3.84 billion US dollars, an increase of 4.3 times compared with that before the reunification. By October 2024, the mainland had absorbed a total of 23.93 billion US dollars of direct investment from Macao, and the mainland had invested 14.19 billion US dollars in Macao.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)